Drug Trial Radar · NCT06572449
Study to Assess Safety and Effectiveness of Slowly Increasing Dose and Food Effect of KarXT in Participants With Schizophrenia
Last checked: Nov 20, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
173
Actual
Start
Oct 28, 2024
Primary completion
Mar 13, 2025
Study completion Mar 13, 2025
Sponsor
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb companyBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Aug 27, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety and efficacy of slowly increasing dose and food effect of KarXT in adult participants with schizophrenia.
Conditions
- Schizophrenia
Interventions
KarXTDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With TEAEs From First Dose to End of Study Follow up.Time frame: From first dose to end of study follow up (63 days)
- Number of Participants With TEAEs at the End of Period 1 and Period 2.Time frame: Period 1 (From first dose to day 28) Period 2 (day 29 to day 56)
- Number of Participants With Serious TEAEs at the End of Period 1 and Period 2.Time frame: Period 1 (From first dose to day 28); Period 2 (day 29 to day 56); Overall (63 days)
- Number of Participants With TEAEs Leading to Treatment Discontinuation.Time frame: Period 1 (From first dose to day 28); Period 2 (day 29 to day 56); Overall (63 days)
- Number of Participants With Pro-cholinergic and Anticholinergic TEAEs.Time frame: Period 1 (From first dose to day 28); Period 2 (day 29 to day 56); Overall (63 days)
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Local Institution - 0002
Los Alamitos, California
Local Institution - 0004
Riverside, California
Local Institution - 0006
Hollywood, Florida
Local Institution - 0005
Atlanta, Georgia
Local Institution - 0003
Decatur, Georgia
Local Institution - 0001
Marlton, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.